Szeto H[au] - Search Results

Year	Number of Results
1964	1
1976	1
1977	1
1978	2
1979	1
1980	4
1981	3
1982	4
1983	2
1985	6
1986	2
1987	2
1988	3
1989	2
1990	7
1991	5
1992	6
1993	5
1994	2
1995	6
1996	7
1997	3
1998	6
1999	4
2000	3
2001	3
2002	9
2003	6
2004	7
2005	5
2006	7
2007	6
2008	7
2009	6
2010	2
2011	6
2012	3
2013	6
2014	11
2015	10
2016	3
2017	5
2018	7
2019	5
2020	6
2021	2
2022	4

1

Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury.

Szeto HH, Liu S, Soong Y, Alam N, Prusky GT, Seshan SV. Szeto HH, et al. Kidney Int. 2016 Nov;90(5):997-1011. doi: 10.1016/j.kint.2016.06.013. Epub 2016 Aug 9. Kidney Int. 2016. PMID: 27519664 Free article.

2

ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes.

Ducasa GM, Mitrofanova A, Mallela SK, Liu X, Molina J, Sloan A, Pedigo CE, Ge M, Santos JV, Hernandez Y, Kim JJ, Maugeais C, Mendez AJ, Nair V, Kretzler M, Burke GW, Nelson RG, Ishimoto Y, Inagi R, Banerjee S, Liu S, Szeto HH, Merscher S, Fontanesi F, Fornoni A. Ducasa GM, et al. Among authors: szeto hh. J Clin Invest. 2019 Jul 22;129(8):3387-3400. doi: 10.1172/JCI125316. eCollection 2019 Jul 22. J Clin Invest. 2019. PMID: 31329164 Free PMC article.

3

Cell-permeable, mitochondrial-targeted, peptide antioxidants.

Szeto HH. Szeto HH. AAPS J. 2006 Apr 21;8(2):E277-83. doi: 10.1007/BF02854898. AAPS J. 2006. PMID: 16796378 Free PMC article. Review.

4

Mitochondrial pharmacology: its future is now.

Szeto HH, James LP, Atkinson AJ. Szeto HH, et al. Clin Pharmacol Ther. 2014 Dec;96(6):629-33. doi: 10.1038/clpt.2014.177. Clin Pharmacol Ther. 2014. PMID: 25399706

5

Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury.

Szeto HH. Szeto HH. Antioxid Redox Signal. 2008 Mar;10(3):601-19. doi: 10.1089/ars.2007.1892. Antioxid Redox Signal. 2008. PMID: 17999629 Review.

6

Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.

Szeto HH. Szeto HH. AAPS J. 2006 Aug 18;8(3):E521-31. doi: 10.1208/aapsj080362. AAPS J. 2006. PMID: 17025271 Free PMC article. Review.

7

Stealth Peptides Target Cellular Powerhouses to Fight Rare and Common Age-Related Diseases.

Szeto HH. Szeto HH. Protein Pept Lett. 2018;25(12):1108-1123. doi: 10.2174/0929866525666181101105209. Protein Pept Lett. 2018. PMID: 30381054 Review.

8

Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging.

Szeto HH, Liu S. Szeto HH, et al. Arch Biochem Biophys. 2018 Dec 15;660:137-148. doi: 10.1016/j.abb.2018.10.013. Epub 2018 Oct 23. Arch Biochem Biophys. 2018. PMID: 30359579 Review.

9

Maternal-fetal pharmacokinetics: summary and future directions.

Szeto HH. Szeto HH. NIDA Res Monogr. 1995;154:203-17. NIDA Res Monogr. 1995. PMID: 8606745 Review. No abstract available.

10

Outcomes After Implementation of a Benzodiazepine-Sparing Alcohol Withdrawal Order Set in an Integrated Health Care System.

Smith JT, Sage M, Szeto H, Myers LC, Lu Y, Martinez A, Kipnis P, Liu VX. Smith JT, et al. Among authors: szeto h. JAMA Netw Open. 2022 Feb 1;5(2):e220158. doi: 10.1001/jamanetworkopen.2022.0158. JAMA Netw Open. 2022. PMID: 35191968 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results